The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
Gold prices are up on Tuesday, with the bright metal now hovering around $4,215 a troy ounce. A better market mood undermines near-term demand for the US Dollar (USD), despite the improved sentiment surging from upbeat United States (US) data.
On the one hand, ADP reported that for the four weeks ending November 22, US private employers added an average of 4,750 jobs per week, an improvement from the previous negative readings. Also, the Job Openings and Labor Turnover Survey (JOLTS) released by the Bureau of Labor Statistics (BLS) showed that the number of job openings on the last business day of September stood at 7.658 million, while for October it rose to 7.67 million. The news initially triggered USD demand, but the Greenback quickly changed course on sentiment.
Now, the focus shifts to the US Federal Reserve (Fed). The central bank is widely anticipated to trim the benchmark interest rate by 25 basis points (bps) after its two-day meeting and announce it on Wednesday. The Fed will also release a fresh Summary of Economic Projections (SEP) in which policymakers share their perspectives on economic and monetary policy developments.
Additionally, the focus is on the upcoming Fed Chair. Jerome Powell will end his mandate in May 2026, and the long-lasting battle with President Donald Trump will come to an end. President Trump has demanded the Fed cut rates at a much faster pace, and the upcoming Chair will likely align with his thinking. Market players are looking for clues in a more aggressive monetary loosening with the new Fed head. Lower borrowing costs are likely to fuel demand for stocks while sending the USD into a selling spiral.
XAU/USD trades at $4,211.37, and the 4-hour chart shows that the 20-period Simple Moving Average (SMA) stabilizes above the 100- and 200-period SMAs, while the longer averages edge higher below the current level, suggesting that buyers have regained control. Price holds just above the shorter one, keeping the near-term tone firm. Technical indicators, however, show that the bullish potential remains limited. The Momentum indicator sits below 0 and falls, while the Relative Strength Index (RSI) stands directionless at 53. A pause in the advance could find initial support at the 20-period SMA at $4,205.76, with a deeper setback exposing the 100-period SMA at $4,150.61.
In the daily chart, XAU/USD remains confined to familiar levels. The 20-day Simple Moving Average (SMA) advances above the 100- and 200-day SMAs, with all three rising while price holds above them. Meanwhile, the Momentum indicator ticks higher within positive levels, while the RSI stands at 60, both keeping the near-term tone positive. A sustained hold over the 20-day SMA would keep the path tilted higher. A break lower would expose the 100-day SMA at $3,792.65 and, if extended, the 200-day SMA at $3,515.46.
(The technical analysis of this story was written with the help of an AI tool)
The British pound is a little bit different in the sense that it continues to try to rally, but it can’t quite hang on to gains. The 1.34 level seems to be a significant barrier. If we can get above there, then it opens up the door to the 1.36 level, although I don’t think it’s a clean and easy move. If we pull back, then the 1.32 area and the 1.3250 area both offer support.
While keeping in mind that the Bank of England is expected to cut rates this month, it will probably have more to do with the press conference in the United States and what they say, mainly because the interest rate differential will essentially be the same at the end of the month and of course markets will be looking forward to try to figure out which one strengthens or weakens.
The euro initially fell against the British pound but has recovered a bit as we just hang around this 50-day EMA. The 0.8750 level is an area that had previously been resistance, so it makes a certain amount of sense that it offers support. That being said, this is a market that had reached a major resistance barrier on longer-term charts and now has pulled back. If you squint, you can make out some type of complex head and shoulders, but really, at this point, I think we’re just kind of waiting around for some type of external news, probably the Bank of England and its statement at its interest rate decision later this month.
That could, in fact, strengthen the euro, or perhaps the Bank of England sounds a little bit more standoffish and maybe a little hesitant to go into a full rate-cutting cycle. And that could turn this pair right back around. The next couple of days are probably pretty choppy, though.
For a look at all of today’s economic events, check out our economic calendar.
If you’re living with diabetes, you likely spend a lot of time planning what goes on your plate. But what about what you pour into your glass or mug? Drinks are easy to overlook. Yet, they can also have a big impact on your blood sugar. On the flip side, not drinking enough can also be a problem, as dehydration may contribute to high blood sugar.
Luckily, there are plenty of blood sugar–friendly beverages out there. One of our favorite sugar-free beverages is tea, which happens to be the second most popular beverage in the world after water. Tea offers loads of health benefits, and better blood sugar is one of them.
With all the different types of teas to choose from, you may be wondering which are the best ones to drink for blood sugar management. To find out, we asked dietitians. Here’s what they told us.
Delicate, earthy green tea is consistently linked to a host of health benefits, including better blood sugar. In fact, research has found that it may help reduce fasting blood glucose and improve insulin sensitivity in people with diabetes. What makes it so effective? “The gut houses trillions of microbes that influence blood sugar levels,” says Kimberley Rose-Francis, RDN, CDCES, LD, a registered dietitian and certified diabetes educator in private practice in Florida. “An imbalanced gut microbiota can lead to decreased glucose tolerance and insulin resistance. Green tea is rich in polyphenols, which are small plant-based compounds associated with various health benefits, including improvements in gut health.”
For a healthy afternoon pick-me-up, brew some soothing Orange-Ginger Tea. Or, enjoy a cup of our no-sugar-added Ginger-Lemon Tea.
Although green and black tea look and taste quite different, they both come from the Camellia sinensis plant. So, it makes sense that they share many of the same potential health benefits. That includes supporting better blood sugar. While there is not as much research on the benefits of black tea for blood glucose management, one review study reports that it may aid in glucose metabolism and improve the body’s sensitivity to its own insulin. Researchers aren’t sure exactly why. However, they note black tea’s abundant polyphenols may slow the digestion and absorption of sugars from food. This, in turn, may protect against weight gain, which is a powerful trigger for type 2 diabetes.
We don’t have to tell you how comforting a cup of black tea is. But it’s also our favorite tea for energy. For an afternoon pick-me-up, try it iced in this zippy Peach Iced Tea.
“Ginger is well-known for its ability to relieve nausea, but it may also help improve blood sugar levels when crushed and brewed into a fragrant tea,” says Rose-Francis. “Research indicates that ginger contains nearly 40 antioxidant compounds, which can be beneficial for treating various inflammatory conditions and may positively impact blood sugar levels over time.”
“Since chronically elevated blood sugar can lead to inflammation, ginger’s anti-inflammatory compounds could be considered a beneficial functional food for achieving better blood sugar balance,” she adds. Beyond the anti-inflammatory properties of ginger, this flavorful root may also help inhibit the absorption of carbohydrates, regulate glucose metabolism and protect the insulin-producing cells of the pancreas.
You may have noticed that ginger already plays a starring role in several recipes in this article. However, if you’re a purist, try our simple Ginger Tea recipe. All you need is water and a few slices of fresh ginger.
Cinnamon is more than a beloved baking spice. It can also be brewed into a delicious tea. “Cinnamon has been studied for its potential benefits of enhancing insulin function and supporting blood sugar,” says Vandana Sheth, RDN, CDCES, FAND, a registered dietitian and certified diabetes educator specializing in plant-based nutrition. “It’s a naturally sweet flavored tea without added sugar, and a good option for those with diabetes.” Like ginger, cinnamon is rich in antioxidants that tackle the chronic inflammation that can make it harder to manage your blood sugar. In fact, several studies have shown that cinnamon powder may help lower blood glucose in people with and without diabetes. And one older study found that cinnamon tea may help reduce blood glucose in people without diabetes.
You can easily brew a cup by steeping cinnamon sticks in water. Or, if you’re craving creamy comfort, combine it with black tea and other spices in a spicy cup of chai tea.
From better brain health to less heart disease, turmeric boasts a long list of health benefits. Research reveals that it may also reduce blood glucose and help with weight management. What makes it so powerful? Turmeric contains an active compound called curcumin, which is a potent anti-inflammatory and antioxidant. And, as you’ve already learned, inflammation and higher blood sugar often go hand-in-hand. No wonder researchers credit curcumin’s blood sugar–managing powers to its anti-inflammatory action.
While you can always brew a simple bag of turmeric tea, there are all kinds of creative ways to use it, like this iced Anti-Inflammatory Golden Tonic. It does contain a touch of honey, but you can feel free to omit it for a sugar-free, blood-sugar-friendly drink.
Relaxing with a cup of tea isn’t just a healthy, flavorful way to hydrate. Research reveals that some types of tea can do good things for your blood sugar. And dietitians agree! According to dietitians, green, black, ginger, cinnamon and turmeric teas are the best teas to drink for better blood sugar. For optimal blood sugar management, choose unsweetened teas or add a squeeze of citrus for natural sweetness. So, what are you waiting for? Get your teapot ready. It’s time to start sipping!
The crypto market cap surged to $3.57 trillion, driven by a 2.07% increase.
The cryptocurrency total trading volume stood at $161.68 billion, up 3.52% in the last 24 hours.
Trading volumes for stablecoins accounted for 90.34% of the total volume at $146.06 billion.
The surge today comes as crypto enthusiasts are looking forward to Donald Trump’s inauguration next week, which is expected to mark the beginning of a historic pro-crypto government in the United States.
The much-anticipated “Crypto Ball” ahead of the inauguration is seen as a potential catalyst for bullish sentiment, with hopes of driving the digital asset sector to new heights this year.
Cooling inflation and expectations of further Federal Reserve rate cuts also contributed to the positive sentiment.
Bitcoin continued its upward trajectory, climbing 1.92% in the past 24 hours to reach $101,611.57.
The Bitcoin price made a high of $102,037 and a low of $97,364.44 in the last 24 hours.
Bitcoin’s dominance dipped slightly by 0.10% to 56.31%.
The cryptocurrency’s market capitalization now stands at over $2 trillion.
Institutional demand played a pivotal role in the rally, with ETFs attracting $98 million in inflows.
Ethereum was down 0.37% in the last 24 hours to hit $3,370.82 .
The coin traded within a range of $3,265 to $3,394.
Its market cap climbed over $406 billion.
Despite mixed sentiment among institutions, ETH-focused ETFs saw $55 million in inflows.
XRP continued its rally on Friday. The coin has registered gains of over 44% in the past seven days.
The XRP price surged 7% to $3.33, reaching a 24-hour high of $3.39.
Ripple CEO Brad Garlinghouse’s comments about the potential inclusion of XRP in US crypto reserves fueled the rise in the coin, making it a standout performer.
At the CfC St. Moritz conference, Garlinghouse said that more central banks are considering using cryptocurrencies for their reserves, citing improved regulatory frameworks.
Garlinghouse also suggested that the evolving regulatory approaches in the United States could potentially facilitate the creation of state-controlled reserves that utilize Ripple’s XRP.
His comments just a day after reports suggested that Donald Trump is open to considering XRP, Solana, and USDC for strategic reserves.
Solana went up close to 5%, trading at $212.90.
Trading volume for the coin was up over 48% at $6.2 billion.
Its market cap reached $103 billion, as investors showed renewed confidence in the blockchain’s growing ecosystem.
Several altcoins outpaced the broader market, with Fartcoin (FARTCOIN) and Vechain (VET)leading the pack, both gaining over 17% in 24 hours.
EOS, Litecoin (LTC) also saw double-digit percentage increases.
Not all cryptocurrencies shared in the bullish momentum. ai16z (AI16Z) fell 12%, leading the list of top losers. Virtuals Protocol (VIRTUAL) and Pudgy Penguins (PENGU) also posted losses.
BNB (BNB) is currently trading at $715.64, showing a slight decrease of 0.19% in the last hour and a modest increase of 0.34% over the past 24 hours.
KuCoin Token (KCS) is currently priced at $11.21, with a slight dip of 0.15% in the last hour but a positive 0.71% gain over the past 24 hours.
FTX Token (FTT) is currently valued at $2.48, having seen a slight increase of 0.44% in the last hour and a more significant 1.77% gain over the past 24 hours.
BitMart Token (BMX) is currently trading at $0.2996, with a minor increase of 0.07% in the last hour but a slight decrease of 0.18% over the past 24 hours.
OX Coin (OX) is currently priced at $0.01831, showing a decrease of 0.30% in the last hour and a more substantial decline of 15.15% over the past 24 hours.
Celsius (CEL) is currently valued at $0.1737, having seen a slight increase of 0.11% in the last hour and a more significant 2.09% gain over the past 24 hours.
Bybit Staked SOL (BBSOL) is currently trading at $224.06, with a minor decrease of 0.10% in the last hour but a positive 4.70% gain over the past 24 hours.
The post Crypto prices on Jan 17: BTC hits $102k, XRP continues bull run appeared first on Invezz
As observed in recent currency price movements, the EUR/USD pair continues to trade within a clear ascending channel. The price recently pulled back from its highs near the psychological barrier of 1.1700 to test support at the channel’s bottom. The EUR/USD price is currently stabilizing around 1.1653, suggesting the potential for another rally if the channel structure holds firm.
Simultaneously, Fibonacci extension levels applied to the recent movement show potential upward targets if the bullish trend resumes. The 0.00% level at 1.1628 represents the base of the current swing, while the 0.382 extension sits at 1.1678. Upward targets include the 0.5 extension at 1.1693, the 0.618 level at 1.1708, and the 0.764 extension at 1.1727. The ultimate target is the 1.0 extension around 1.1757 if the bullish momentum accelerates.
The 100-day Simple Moving Average (SMA) is situated above the 200-day SMA, confirming that the current stronger path is upward, or that the rally is more likely to gain momentum rather than reverse. Both moving averages are sloping upward and lie below the current price action, indicating they may form dynamic support for any further pullbacks. Additionally, the Stochastic oscillator is rising from the oversold area, suggesting buyers are beginning to regain control after the recent correction. The oscillator has room to rise before reaching an overbought state, meaning bullish momentum may increase in the near term.
The Relative Strength Index (RSI) is also turning bullish from the lower half of its range, reflecting renewed buying interest. The oscillator has ample room to rise, suggesting that the EUR/USD pair may continue its upward trajectory if channel support holds and buyers remain committed to pushing prices towards the Fibonacci extension targets.
According to Forex currency trading experts, the EUR/USD pair may be affected by the upcoming FOMC statement, where the Federal Reserve is widely expected to cut interest rates but may signal a more cautious outlook toward neutrality in 2026. Consequently, more hawkish comments from Fed Chair Powell could cause the US Dollar to rise, but it should also be noted that his term is nearing its end.
Prior to that, the Euro/Dollar will react today to the announcement of German Trade Balance figures at 09:00 AM Egypt time, followed by the more important release of the US ADP Non-Farm Employment Change and the JOLTS Job Openings reading at 17:00 PM Egypt time. Euro trading was already influenced by signals from European Central Bank officials, as ECB board member Schnabel stated that she was comfortable with market bets that the ECB’s next move might be an interest rate hike, noting that the risks to both growth and inflation are now tilted to the upside. She also suggested that the updated economic projections in December might be revised higher.
Overall, her comments, coupled with the resilience of economic activity and inflation nearing the target level, reinforced expectations that the ECB would keep interest rates unchanged until 2026.
As predicted, the EUR/USD pair will remain within a narrow range with no clear direction until the market reacts to the US Federal Reserve’s announcement tomorrow and any signals regarding its future policies until Powell’s term ends. Be cautious and don’t rush into anything.
Ready to trade our Forex daily forecast? We’ve shortlisted the best currency trading platforms in the industry for you.
Echinacea is a popular herbal supplement people often reach for during the cold season, but its effects go beyond the immune system.
Echinacea is best known for helping your immune system respond to viruses. Some people take echinacea supplements when they feel a cold coming on, although research on its effectiveness is mixed. Several studies suggest that it may help alleviate respiratory symptoms. However, more research is needed.
Echinacea has anti-inflammatory compounds that may help calm skin redness, itching, and breakouts. Early research has shown potential benefits for conditions like:
Some small studies look promising, but more research is still needed—especially in humans.
Echinacea contains plant compounds that may help your body dial down inflammation. A few preliminary studies show it may help:
Human research is limited, but echinacea has a long history of traditional use for pain relief.
Some small human trials suggest echinacea may have a calming effect. Participants taking 40 to 80 milligrams (mg) of echinacea saw improvements in:
These findings are early and not definitive, but they highlight a potential mental health benefit beyond immunity.
Echinacea contains compounds called caffeic acid derivatives that may influence how your body absorbs glucose. Early research suggests potential benefits related to blood sugar management. However, this area remains under investigation.
Native American communities have utilized echinacea for generations due to its healing properties. Today, it’s still used in many forms, and its traditional uses go far beyond immune support.
Traditionally, echinacea was used for:
Traditional practices have guided echinacea use for generations, and although research is ongoing, there isn’t quite enough modern evidence to confirm these effects.
It’s best to review supplement labels with a healthcare provider to discuss any potential interactions with other supplements or medications. It’s also vital that you carefully read the ingredient list and nutrition facts panel of a supplement to know which ingredients are included.
If you’re exploring herbal options with overlapping benefits, you may also see:
Always use only one supplement at a time for a specific goal, and consult with a healthcare provider or pharmacist before use.
As Monday trading kicks off the second week of December, the Solana Price Prediction models are signaling a critical juncture for the Layer-1 giant. While SOL attempts to stabilize following a volatile weekend, market sentiment is shifting rapidly. According to the latest reports from CoinDesk and crypto analysis on X (Twitter), while ETF rumors provide a safety net, retail liquidity is aggressively rotating elsewhere.
Investors searching for the best crypto to buy now are looking past the saturated Layer-1 market and towards high-utility infrastructure plays. Smart money is increasingly using the current stability as an exit liquidity event, moving capital into a CertiK-verified “PayFi” giant that has just launched its mobile wallet on the App Store. This emerging protocol, often dubbed “XRP 2.0,” is capturing headlines as the early stage crypto investment of the year.
As the Solana Price Prediction charts show signs of exhaustion, the narrative is pivoting to projects that bridge the gap between digital wallets and local bank accounts instantly, offering the explosive growth that SOL can no longer guarantee.
The current Solana Price Prediction hangs precariously on the hopes of a spot ETF approval in the US. While whales have stepped in to defend the $130 support level, the momentum required to shatter all-time highs appears to be fading.

Data from centralized exchanges shows a decrease in spot buying volume, suggesting that the “easy money” phase for Solana is over. Traders are becoming wary of the heavy bag-holders waiting to sell at resistance, capping the upside potential for new entrants.
Furthermore, on-chain metrics reveal that while the ecosystem is active, the value capture for the SOL token is lagging behind high growth crypto assets in the presale sector. Analysts warn that if the Solana Price Prediction fails to turn bullish above $150 this week, a retest of lower support zones is likely.
This uncertainty is driving a migration of capital. Savvy investors are realizing that while Solana is a great technology, it is already a massive cap asset. The hunt for the next 100x crypto is leading them away from the established giants and into undervalued crypto projects that are entering their price discovery phase with live products and massive community backing.
While the Solana Price Prediction remains uncertain, Remittix is executing a masterclass in growth. This project has surged to the #1 spot on “must-watch” lists because it isn’t waiting for a bull run to deliver utility, it is doing it right now. Remittix has just released its wallet on the Apple App Store, moving from a presale promise to a tangible product you can download today.
This execution has earned it the #1 Global Rank on CertiK for pre-launch tokens, a level of security validation that has whales dumping stagnant assets to buy RTX tokens.
Remittix is solving the off-ramp problem that keeps crypto stuck in the digital void. Analysts are calling it “XRP 2.0” because it bridges the gap to the real world instantly, without the centralized baggage or regulatory headaches. While Solana fights for network stability, Remittix users are downloading the app. This is the top crypto under $1 that savvy investors are loading up on before the public listings send it parabolic.
The Remittix Wallet is officially LIVE on the Apple App Store! This is a historic milestone, allowing users to securely store and manage assets immediately. The highly anticipated crypto-to-fiat “PayFi” functionality is coming in December, which will likely send demand skyrocketing.
To celebrate, the team is running a massive $250,000 giveaway with over 370,000 entries already logged. Don’t rely solely on a stagnant Solana Price Prediction; secure your position in the fastest growing crypto 2025 today.
Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/
Socials: https://linktr.ee/remittix
$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway
Most analysts see the Solana Price Prediction stabilizing near $300, but growth percentages will be lower than presales like Remittix.
Remittix is currently the best crypto to buy now due to its live App Store wallet and #1 CertiK ranking.
A rejection could negatively impact the Solana Price Prediction, causing investors to flee to utility tokens like RTX.
Tracking CertiK leaderboards and following news for product launches (like the Remittix wallet) is the best strategy.
Risk is reduced when a project has a live product on the App Store (like Remittix) compared to speculative assets dependent on the Solana Price Prediction.
Brittany Barreto, Ph.D., is a podcaster, an entrepreneur, and a molecular and human geneticist. (In other words, she’s really smart.) Read her column here each month to learn about what’s happening in the world of technology and innovation in women’s health.
Painful periods can be more than an inconvenience. Menstrual pain, officially called dysmenorrhea, affects up to 9 out 10 people who menstruate at some point in their lives. But, for 5% to 10% of women, cramps can be so intense that they interfere with work, school or daily life.
Traditional treatments like over-the-counter pain medication or heating pads don’t work for everyone. But thanks to advances in wearable and neuromodulation technology, new tools are offering drug-free ways to manage menstrual pain and even help some users reduce heavy flow and fatigue.
Here’s a look at four emerging devices designed to interrupt menstrual pain signals: Livia, OhmBody, Jovi and Samphire.
Livia: Turning menstrual pain “off” with micro-pulses
(Photo/Courtesy of Livia)
Livia is a compact wearable FDA-cleared device that uses patented SmartWave micro-pulse technology to block pain signals before they reach the brain. Worn discreetly under clothing, the device delivers gentle electrical pulses to the lower abdomen.
This approach, based on the gate control theory of pain,reduces pain perception and stimulates endorphin release. Relief can begin within 30 to 60 seconds of turning it on.
Several double-blind, randomized clinical studies have shown that Livia significantly reduces pain in people with primary dysmenorrhea (period pain without an underlying condition). Livia is FDA-cleared, Health Canada-approved and CE marked for use in the European Union.
The device is sold online and through major U.S. retailers like CVS. However, it’s not currently covered by insurance, meaning users must pay for the device out of pocket.
OhmBody: A brain-based approach to lighter, calmer cycles
OhmBody takes a different route than Livia, targeting the vagus and trigeminal nerves through small earpieces rather than the abdomen. These nerves help regulate the body’s “rest-and-digest” versus “fight-or-flight” response, which can be helpful during menstruation, when the nervous system often shifts into stress mode. OhmBody’s gentle neurostimulation aims to help with pain, reduce blood loss and improve mood.
OhmBody has been clinically tested for safety. The peer-reviewed study was conducted by Spark Biomedical, OhmBody’s parent company, and it was very small — but the early results were promising. In this pilot trial of 16 participants, use of the wearable neurostimulation device was associated with a reduction in menstrual blood loss, shorter periods, and improvements in pain and quality-of-life scores.
While these findings are encouraging, it’s important to note that OhmBody is currently marketed as a wellness device, not a medical treatment. That means it’s not FDA-cleared for menstrual pain and is not covered by insurance. If you want to use OhmBody, you must purchase it directly from the company and pay for it out of pocket. You may be able to use funds from your HSA or FSA account to buy OhmBody, but you’ll have to check your plan rules to find out.
Jovi: A reusable patch without electricity
Jovi looks like a flexible sticker, but it uses a unique signal-filtering technology made from microscopic conductive particles to reduce pain. Unlike OhmBody and Livia, instead of sending pulses into the body, Jovi claims to “absorb and reroute” pain signals, similar to tuning out static on a radio.
Jovi patches can be worn anywhere on the body and are reusable for up to a year. They’re drug-free and water-resistant. As wellness devices, they are not FDA-cleared, but they are eligible for HSA/FSA purchases. While Jovi’s approach is different from electrical or heat-based devices, it’s still an emerging technology. Early customer feedback has been positive, and many users report noticeable relief, though additional independent research would help confirm its effectiveness. Jovi is available online in the U.S. and prices start at $159 per patch.
Samphire: Menstrual care that starts in the brain

(Photo/ Courtesy of Samphire)
Samphire Neuroscience is a London-based company pioneering brain-based approaches to menstrual health, addressing both menstrual cramps and hormone-influenced mood shifts. Its first product, Nettle, is a CE-certified medical device (meaning it has met rigorous health, safety and environmental requirements in the EU) intended to help manage pain and mood changes related to PMS, premenstrual dysphoric disorder (PMDD) and endometriosis. Nettle is currently available only in the EU and the UK.
Samphire’s upcoming U.S. device, Lutea, uses similar non-invasive brain stimulation (tDCS), a gentle, low-level electrical current applied through electrodes on the scalp. Clinical studies show that tDCS can safely modulate brain activity linked to mood and pain perception.
Lutea is marketed as a wellness device, meaning it doesn’t make medical claims and is not yet FDA-approved. The company expects to pursue approval as research expands. In fact, Samphire is actively recruiting participants to study their product’s ability to modulate pain and emotional regulation in patients with endometriosis in London and California. Preorders for U.S. buyers are open, but insurance coverage is not available — and the price is steep, starting at $589.
From pain to progress
For decades, women have had limited, often unsatisfying options for menstrual pain relief. Now, a wave of wearable and brain-based technologies is offering new hope and proof that women’s health innovation is finally catching up.
Still, most of these devices are not yet covered by insurance and are not intended to replace medical care. Anyone with severe pain, heavy bleeding or conditions like endometriosis or fibroids should talk with a healthcare provider before using new devices.
These tools represent an important shift, one that moves menstrual pain from something women are expected to tough out to something science can actually solve.
The information about products and/or services in this column does not constitute any form of endorsement or recommendation by HealthyWomen. Links are provided as a convenience and for informational purposes only. This column may occasionally cover companies in which Brittany Barreto is an investor.
From Your Site Articles
Related Articles Around the Web
The EURNZD continued forming clear negative movement, affected by the continuation of forming strong barrier at 2.0335 level, suffering some losses by its stability near 2.0120, noting that the continuation of stochastic stability within the oversold level will increase the negative pressure on the current trading, to pave the way for reaching the initial target at 2.0060. Breaking this barrier might extend the losses towards 1.9955 directly, to face the moving average of 55.
While the stability above 2.0060 level will force it to form mixed trading, and there is a chance for recovering some losses by its rally towards 2.0210 before any attempt to reach the previously suggested negative target.
The expected trading range for today is between 2.0060 and 2.0175
Trend forecast: Bearish
Copper price ended yesterday’s trading by providing new closure near $5.3200 level, taking advantage of stochastic positivity by providing chances for resuming the bullish attack that depends on several factors, one of them is the stability within the bullish channel levels besides forming extra support at $5.1300.
Therefore, we keep the bullish scenario, waiting for reaching %161.8 Fibonacci extension level at $5.5000, and surpassing it will open the way for achieving extra gains in the upcoming period.
The expected trading range for today is between $5.2500 and $5.5000
Trend forecast: Bullish